about
Novel pyrazine analogs of chalcones: synthesis and evaluation of their antifungal and antimycobacterial activity.Study of hydrophobic properties of biologically active open analogues of flavonoids.Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer's disease treatment.Monooxime-monocarbamoyl Bispyridinium Xylene-Linked Reactivators of Acetylcholinesterase-Synthesis, In vitro and Toxicity Evaluation, and Docking Studies.Synthesis and characterization of (Z)-5-arylmethylidene-rhodanines with photosynthesis-inhibiting properties.Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.In vitro antiplatelet activity of flavonoids from Leuzea carthamoides.Preparation, in vitro screening and molecular modelling of symmetrical 4-tert-butylpyridinium cholinesterase inhibitors--analogues of SAD-128.7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase.Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.Synthesis and Antifungal Screening of 2-{[1-(5-Alkyl/arylalkylpyrazin-2-yl)ethylidene]hydrazono}-1,3-thiazolidin-4-ones.Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine—new tacrine derivate with cholinergic propertiesDevelopment and validation of a liquid chromatography method for the simultaneous determination of α-tocopherol, retinol and retinyl esters in human serum using a monolithic column for the monitoring of anticancer therapy side effects
P50
Q41545511-D7E3F695-C890-4EBA-869E-B6116B7608F9Q42679951-40768B3B-2E94-4F90-8FFE-103EF8CE5630Q42787028-6DCD1C39-CD12-40DC-9E27-9808CD928522Q43199541-64988C2F-E054-4718-A6B0-90AAE37002FCQ46084715-5960A151-0991-4C2C-810B-9FFB8CAEAA46Q46432540-895D890A-EB42-4223-AF9F-F28D6B6767E4Q46831566-CE8F41AD-E78A-4C2F-8505-7448F16E62EDQ46960203-FFAE7C7D-FD4E-49D9-9E90-038955B33630Q47633294-7A3FA80A-140D-402C-8792-E46B455FCBE4Q52678164-745D76E2-2F26-4242-9924-F861815A248DQ52683047-91632928-D716-411A-8934-AFA1D8E7AC2EQ53312514-1C3E2B7A-BD2C-4D07-A8C8-1D26A18E6BA4Q53663010-5C0CD5A3-A764-4EFD-B24F-B9FC532BF8E0Q60949581-2F869C69-7BD1-48FC-9471-AD94BE978BE6Q61885635-BBE02E03-548F-42DE-8B27-9FFE3462BC4D
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Veronika Opletalova
@ast
Veronika Opletalova
@en
Veronika Opletalova
@es
Veronika Opletalova
@nl
Veronika Opletalova
@sl
Veronika Opletalová
@cs
type
label
Veronika Opletalova
@ast
Veronika Opletalova
@en
Veronika Opletalova
@es
Veronika Opletalova
@nl
Veronika Opletalova
@sl
Veronika Opletalová
@cs
prefLabel
Veronika Opletalova
@ast
Veronika Opletalova
@en
Veronika Opletalova
@es
Veronika Opletalova
@nl
Veronika Opletalova
@sl
Veronika Opletalová
@cs
P214
P1053
A-5935-2008
P106
P1343
P21
P214
P31
P3829
P496
0000-0001-7234-3246
P691
jn20000620259
P735
P7859
lccn-n2004153507